Digital therapeutics (DTx) company Virta Health scored $133 million in a Series E funding round led by Tiger Global, which it’ll use to expand its telehealth-powered diabetes reversal program across the US and support R&D of its products. Virta currently works with over 100 healthcare organizations and treats patients across all 50 states.
Virta Health’s pandemic-era growth underscores how chronic disease treatment is shifting beyond traditional medication—and that’s translating into massive savings for payers:
While most DTx solutions target chronic diseases, we think DTx players would be wise to support payers’ social determinants of health (SDOH) initiatives to reach underserved communities.
11 Times SquareNew York, NY 100361-800-405-0844